UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 417

Sortiert nach

Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: What we know and future landscape

Journal of cellular physiology, 2020-01, Vol.235 (1), p.74-86

2020

Link zum Volltext

Verfügbarkeit prüfen

A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice

Science (American Association for the Advancement of Science), 2011-06, Vol.332 (6037), p.1565-1568

2011

Link zum Volltext

Verfügbarkeit prüfen

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

Frontiers in oncology, 2019-09, Vol.9, p.953-953

2019

Link zum Volltext

Verfügbarkeit prüfen

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

Theranostics, 2023, Vol.13 (2), p.704-723

2023

Link zum Volltext

Verfügbarkeit prüfen

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Cancers, 2022-08, Vol.14 (15), p.3758

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular engineering of exocytic vesicle traffic enhances the productivity of Chinese hamster ovary cells

Biotechnology and bioengineering, 2009-03, Vol.102 (4), p.1170-1181

2009

Link zum Volltext

Verfügbarkeit prüfen

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer

Oncogene, 2019-01, Vol.38 (5), p.622-636

2019

Link zum Volltext

Verfügbarkeit prüfen

CRISPRing KRAS : A Winding Road with a Bright Future in Basic and Translational Cancer Research

Cancers, 2024-01, Vol.16 (2), p.460

2024

Link zum Volltext

Verfügbarkeit prüfen

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11949

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells

Biotechnology and bioengineering, 2011-03, Vol.108 (3), p.611-620

2011

Link zum Volltext

Verfügbarkeit prüfen

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.1758835920971421-1758835920971421

2020

Link zum Volltext

Verfügbarkeit prüfen

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma

Cancers, 2021-03, Vol.13 (7), p.1561

2021

Link zum Volltext

Verfügbarkeit prüfen

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

BMC cancer, 2016-02, Vol.16 (1), p.125-125, Article 125

2016

Link zum Volltext

Verfügbarkeit prüfen

CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.661-672

2020

Link zum Volltext

Verfügbarkeit prüfen

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

EMBO molecular medicine, 2021-09, Vol.13 (9), p.e13193-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma

British journal of cancer, 2018-07, Vol.119 (1), p.65-75

2018

Link zum Volltext

Verfügbarkeit prüfen

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses

Cancers, 2022-10, Vol.14 (20), p.4997

2022

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment

Cancer cell international, 2019-11, Vol.19 (1), p.317-317, Article 317

2019

Link zum Volltext

Verfügbarkeit prüfen

Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma

Cancers, 2020-08, Vol.12 (8), p.2310

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model

Scientific reports, 2017-09, Vol.7 (1), p.10636-13, Article 10636

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549

Neoplasia (New York, N.Y.), 2019-02, Vol.21 (2), p.185-196

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight

Frontiers in oncology, 2020-09, Vol.10, p.579464-579464

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma

Translational lung cancer research, 2021-04, Vol.10 (4), p.1857-1872

2021

Link zum Volltext

Verfügbarkeit prüfen

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity

Cancers, 2020-11, Vol.12 (11), p.3389

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.25-25, Article 25

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(390)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(298)
Life Sciences & Biomedicine
(190)
Humans
(81)
Physical Sciences
(74)
Technology
(71)
Chemistry
(46)
Male
(46)
Animals
(42)
Female
(42)
Oncology
(38)
Engineering
(35)
Biochemistry & Molecular Biology
(32)
Materials Science
(29)
Proteins
(29)
Middle Aged
(26)
Gene Expression
(25)
Adult
(24)
Tumors
(24)
Materials Science, Multidisciplinary
(23)
Lung Cancer
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: What we know and future landscape

A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Molecular engineering of exocytic vesicle traffic enhances the productivity of Chinese hamster ovary cells

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer

CRISPRing KRAS : A Winding Road with a Bright Future in Basic and Translational Cancer Research

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma

Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment

Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma

Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model

Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight

Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

Suchergebnisse filtern